For condition: Hidradenitis Suppurativa
COMPASS 2-HS – Adult’s Hidradenitis Suppurativa Study (40 Weeks)
Study Summary
Who Can Participate?
Males or females aged ≥18 to ≤75 years with moderate to severe hidradenitis suppurativa (HS) may participate.
Inclusion Criteria
• have a diagnosis of HS based on clinical history and physical examination for at least ≥1 year
• have HS lesions present in at least 2 distinct anatomic areas
• have HS defined as a total of ≥5 inflammatory lesions (ie, number of abscesses plus number of inflammatory nodules)
• have either had an inadequate response, had intolerance, or had recurrence after ≥3 months systemic antibiotic for treatment of HS
Participant Information
• Participate and receive study treatment at no cost
• Regular visits with study doctors who specialise in treating HS (up to 22 visits)
• Will receive an investigative subcutaneous treatment (study drug) and a placebo
• Reimbursement for study-related expenses may be provided
For more information about this trial, please visit ClinicalTrials.gov
